Quality-by-design-based development of ultradeformable nanovesicular transgelosome of standardized Piper longum extract for melanoma

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Albuquerque KRS, Pacheco NM, del Rosario Loyo Casao T, de Melo FCSA, Novaes RD, Goncalves RV. Applicability of plant extracts in preclinical studies of melanoma: a systematic review. Mediators Inflamm. 2018, 1–28 (2018). •• Provides exhaustive information on the preclinical anticancer potential of numerous plant extracts in melanoma.
  Google Scholar
• 2. Ravikumar P, Tatke P. Design of an encapsulated topical formulation for chemoprevention of skin cancer. Int. J. Pharm. Sci. Res. 10, 309–319 (2019).
  CASGoogle Scholar
• 3. National Institutes of Health (NIH)-2023. Cancer stat facts: melanoma of the skin. National Cancer Institute (NCI). https://seer.cancer.gov/statfacts/html/melan.html
  Google Scholar
• 4. Li J, Zhang Y, Tao J. Targeted nanoparticles for drug delivery to melanoma: from bench to bedside. Nanosci. Dermatol. 203–215 (2016).
  Google Scholar
• 5. Li J, Wang Y, Liang R et al. Recent advances in targeted nanoparticles drug delivery to melanoma. Nanomedicine 11(3), 769–794 (2015).
  Medline CASGoogle Scholar
• 6. Kratz F, Senter P, Steinhagen H. Drug Delivery in Oncology: from Basic Research to Cancer Therapy. John Wiley & Sons, Weinheim, Germany, 1–1689 (2013). •• Detailed information on solid tumors, pathophysiology and the limitations of conventional chemotherapy, drug-delivery systems and nanocarrier-based drug delivery.
  Google Scholar
• 7. Shreya S, Kasote D, Mohapatra D et al. Chemometric-based analysis of metabolomics studies of bioactive fractions of Pleurotus osteratus and their correlation with in vitro anti-cancer activity. Appl. Biochem. Biotechnol. 195(7), 4602–4616 (2023).
  Medline CASGoogle Scholar
• 8. Shreya S, Kumar DN, Mohapatra D et al. Tracing the anti-cancer mechanism of Pleurotus osteratus by the integrative approach of network pharmacology and experimental studies. Appl. Biochem. Biotechnol. 195(1), 152–171 (2023). •• Demonstrated the anticancer activity of natural products through multitargeting mechanisms.
  Medline CASGoogle Scholar
• 9. Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J. Nat. Prod. 83(3), 770–803 (2020). •• Provides comprehensive information on the importance of natural products as drugs for numerous diseases.
  Medline CASGoogle Scholar
• 10. Kinjo J, Nakano D, Fujioka T, Okabe H. Screening of promising chemotherapeutic candidates from plants extracts. J. Nat. Med. 70(3), 335–360 (2016).
  Medline CASGoogle Scholar
• 11. Kumar S, Kamboj J, Sharma S. Overview for various aspects of the health benefits of Piper longum linn. fruit. J. Acupunct. Meridian Stud. 4(2), 134–140 (2011).
  MedlineGoogle Scholar
• 12. Pradeep C, Kuttan G. Piperine is a potent inhibitor of nuclear factor-κB (NF-κB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells. Int. Immunopharmacol. 4(14), 1795–1803 (2004).
  Medline CASGoogle Scholar
• 13. Sunila E, Kuttan G. Piper longum inhibits VEGF and proinflammatory cytokines and tumor-induced angiogenesis in C57BL/6 mice. Int. Immunopharmacol. 6(5), 733–741 (2006).
  Medline CASGoogle Scholar
• 14. Pradeep C, Kuttan G. Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice. Clin. Exp. Metastasis 19(8), 703–708 (2002).
  Medline CASGoogle Scholar
• 15. Fofaria NM, Kim S-H, Srivastava SK. Piperine causes G1 phase cell cycle arrest and apoptosis in melanoma cells through checkpoint kinase-1 activation. PLOS ONE 9(5), 1–10 (2014).
  Google Scholar
• 16. Kim KS, Kim JA, Eom SY, Lee SH, Min KR, Kim Y. Inhibitory effect of piperlonguminine on melanin production in melanoma B16 cell line by downregulation of tyrosinase expression. Pigment Cell Res. 19(1), 90–98 (2006).
  Medline CASGoogle Scholar
• 17. Brożyna AA, Jóźwicki W, Carlson JA, Slominski AT. Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma. Hum. Pathol. 44(10), 2071–2074 (2013).
  MedlineGoogle Scholar
• 18. Song X, Gao T, Lei Q, Zhang L, Yao Y, Xiong J. Piperlongumine induces apoptosis in human melanoma cells via reactive oxygen species mediated mitochondria disruption. Nutr. Cancer 70(3), 502–511 (2018).
  Medline CASGoogle Scholar
• 19. Anita C, Munira M, Mural Q, Shaily L. Topical nanocarriers for management of rheumatoid arthritis: a review. Biomed. Pharmacother. 141, doi:10.1016/j.biopha.2021.111880 (2021).
  MedlineGoogle Scholar
• 20. Kumar A, Pathak K, Bali V. Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discov. Today 17(21–22), 1233–1241 (2012).
  Medline CASGoogle Scholar
• 21. Fernández-García R, Lalatsa A, Statts L, Bolás-Fernández F, Ballesteros MP, Serrano DR. Transferosomes as nanocarriers for drugs across the skin: quality by design from lab to industrial scale. Int. J. Pharm. 573, doi:10.1016/j.ijpharm.2019.118817 (2020). •• Provides detailed information on quality-by-design-based development of transferosome and the influence of various critical processing parameters and critical material attributes on desired responses.
  MedlineGoogle Scholar
• 22. Sahu AN, Mohapatra D. Nanovesicular transferosomes for the topical delivery of plant bioactives. Nanomedicine (Lond.) 16(28), 2491–2495 (2021). •• Provides concise information on the importance of ultradeformable nanovesicular transferosome for transdermal delivery of isolated bioactive phytoconstituents and plant extracts.
  CASGoogle Scholar
• 23. Ahad A, Al-Saleh AA, Al-Mohizea AM et al. Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate. Saudi Pharm. J. 25(7), 1040–1046 (2017).
  MedlineGoogle Scholar
• 24. Habib BA, Sayed S, Elsayed GM. Enhanced transdermal delivery of ondansetron using nanovesicular systems: fabrication, characterization, optimization and ex-vivo permeation study – Box-Cox transformation practical example. Eur J. Pharm. Sci. 115, 352–361 (2018).
  Medline CASGoogle Scholar
• 25. González-Rodríguez M, Arroyo C, Cózar-Bernal M et al. Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process. Drug Dev. Ind. Pharm. 42(10), 1683–1694 (2016).
  Medline CASGoogle Scholar
• 26. Elkomy MH, El Menshawe SF, Abou-Taleb HA, Elkarmalawy MH. Loratadine bioavailability via buccal transferosomal gel: formulation, statistical optimization, in vitro/in vivo characterization, and pharmacokinetics in human volunteers. Drug Deliv. 24(1), 781–791 (2017).
  Medline CASGoogle Scholar
• 27. Mohapatra D, Kumar DN, Shreya S et al. Quality by design–based development and optimization of fourth-generation ternary solid dispersion of standardized Piper longum extract for melanoma therapy. Drug Deliv. Transl. Res. 1–38 (2023).
  Google Scholar
• 28. Arora D, Khurana B, Nanda S. DoE directed optimization, development and evaluation of resveratrol loaded ultradeformable vesicular cream for topical antioxidant benefits. Drug Dev. Ind. Pharm. 46(2), 227–235 (2020). • Demonstrates the central composite design-based development of transferosome.
  Medline CASGoogle Scholar
• 29. Al Shuwaili AH, Rasool BKA, Abdulrasool AA. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline. Eur. J. Pharm. Biopharm. 102, 101–114 (2016).
  MedlineGoogle Scholar
• 30. Balata GF, Faisal MM, Elghamry HA, Sabry SA. Preparation and characterization of ivabradine HCl transfersomes for enhanced transdermal delivery. J. Drug Deliv. Sci. Technol. 60, doi:10.1016/j.jddst.2020.101921 (2020).
  Google Scholar
• 31. Morsi NM, Aboelwafa AA, Dawoud MH. Improved bioavailability of timolol maleate via transdermal transfersomal gel: statistical optimization, characterization, and pharmacokinetic assessment. J. Adv. Res. 7(5), 691–701 (2016).
  Medline CASGoogle Scholar
• 32. Pitta SK, Dudhipala N, Narala A, Veerabrahma K. Development of zolmitriptan transfersomes by Box–Behnken design for nasal delivery: in vitro and in vivo evaluation. Drug Dev. Ind. Pharm. 44(3), 484–492 (2018).
  Medline CASGoogle Scholar
• 33. Dudhipala N, Phasha Mohammed R, Adel Ali Youssef A, Banala N. Effect of lipid and edge activator concentration on development of aceclofenac-loaded transfersomes gel for transdermal application: in vitro and ex vivo skin permeation. Drug Dev. Ind. Pharm. 46(8), 1334–1344 (2020). • Demonstrates the formulation and development of transferosomal gel and its evaluation.
  Medline CASGoogle Scholar
• 34. Păvăloiu R-D, Sha'at F, Bubueanu C et al. Polyphenolic extract from Sambucus ebulus L. leaves free and loaded into lipid vesicles. Nanomaterials 10(1), 56 (2019).
  MedlineGoogle Scholar
• 35. Khan MA, Pandit J, Sultana Y et al. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study. Drug Deliv. 22(6), 795–802 (2015).
  Medline CASGoogle Scholar
• 36. Avadhani KS, Manikkath J, Tiwari M et al. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage. Drug Deliv. 24(1), 61–74 (2017).
  Medline CASGoogle Scholar
• 37. Pathak K, Sharma V, Sharma M. Optimization, in vitro cytotoxicity and penetration capability of deformable nanovesicles of paclitaxel for dermal chemotherapy in Kaposi sarcoma. Artif. Cells Nanomed. Biotechnol. 44(7), 1671–1683 (2016).
  Medline CASGoogle Scholar
• 38. Manca ML, Mir-Palomo S, Caddeo C et al. Sorbitol-penetration enhancer containing vesicles loaded with baicalin for the protection and regeneration of skin injured by oxidative stress and UV radiation. Int. J. Pharm. 555, 175–183 (2019).
  Medline CASGoogle Scholar
• 39. Saoji SD, Raut NA, Dhore PW, Borkar CD, Popielarczyk M, Dave VS. Preparation and evaluation of phospholipid-based complex of standardized centella extract (SCE) for the enhanced delivery of phytoconstituents. Am. Assoc. Pharm. Sci. 18, 102–114 (2016).
  CASGoogle Scholar
• 40. Badria FA, Abdelaziz AE, Hassan AH, Elgazar AA, Mazyed EA. Development of provesicular nanodelivery system of curcumin as a safe and effective antiviral agent: statistical optimization, in vitro characterization, and antiviral effectiveness. Molecules 25(23), 5668 (2020).
  Medline CASGoogle Scholar
• 41. El-Gizawy SA, Nouh A, Saber S, Kira AY. Deferoxamine-loaded transfersomes accelerates healing of pressure ulcers in streptozotocin-induced diabetic rats. J. Drug Deliv. Sci. Technol. 58, doi:10.1016/j.jddst.2020.101732 (2020).
  Google Scholar
• 42. Mangrulkar S, Shah P, Navnage S, Mazumdar P, Chaple D. Phytophospholipid complex of caffeic acid: development, in vitro characterization, and in vivo investigation of antihyperlipidemic and hepatoprotective action in rats. AAPS PharmSciTech 22, 1–16 (2021).
  Google Scholar
• 43. Kumar DN, Chaudhuri A, Dehari D et al. Combination therapy comprising paclitaxel and 5-fluorouracil by using folic acid functionalized bovine milk exosomes improves the therapeutic efficacy against breast cancer. Life 12(8), 1143 (2022).
  Medline CASGoogle Scholar
• 44. Rowe RC, Sheskey P, Quinn M. Handbook of Pharmaceutical Excipients. Royal Pharmaceutical Society, London, UK (2009).
  Google Scholar
• 45. Badr-Eldin SM, Ahmed OA. Optimized nano-transfersomal films for enhanced sildenafil citrate transdermal delivery: ex vivo and in vivo evaluation. Drug Des. Devel. Ther. 10, 1323–1333 (2016).
  Medline CASGoogle Scholar
• 46. Ahad A, Al-Saleh AA, Al-Mohizea AM et al. Formulation and characterization of phospholipon 90 G and Tween 80 based transfersomes for transdermal delivery of eprosartan mesylate. Pharm. Dev. Technol. 23(8), 787–793 (2018).
  Medline CASGoogle Scholar
• 47. Waheed A, Aqil M, Ahad A et al. Improved bioavailability of raloxifene hydrochloride using limonene containing transdermal nano-sized vesicles. J. Drug Deliv. Sci. Technol. 52, 468–476 (2019).
  CASGoogle Scholar
• 48. Mahmood S, Taher M, Mandal UK. Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application. Int. J. Nanomed. 9, 4331 (2014). •• Clearly demonstrated the experimental outcomes of ‘design of experiment’ for the development of transferosome vesicles.
  MedlineGoogle Scholar
• 49. Khatoon K, Rizwanullah M, Amin S, Mir SR, Akhter S. Cilnidipine loaded transfersomes for transdermal application: formulation optimization, in-vitro and in-vivo study. J. Drug Deliv. Sci. Technol. 54, 101303 (2019).
  CASGoogle Scholar
• 50. Bnyan R, Khan I, Ehtezazi T et al. Formulation and optimisation of novel transfersomes for sustained release of local anaesthetic. J. Pharm. Pharmacol. 71(10), 1508–1519 (2019).
  Medline CASGoogle Scholar
• 51. Parkash V, Maan S, Chaudhary V, Jogpal V, Mittal G, Jain V. Implementation of design of experiments in development and optimization of transfersomal carrier system of tacrolimus for the dermal management of psoriasis in albino Wistar rat. J. Bioequivalence Bioavailab. 10, 98–105 (2018).
  Google Scholar
• 52. Chaudhary H, Kohli K, Kumar V. Nano-transfersomes as a novel carrier for transdermal delivery. Int. J. Pharm. 454(1), 367–380 (2013).
  Medline CASGoogle Scholar
• 53. Mohapatra D, Alam MB, Pandey V et al. Carbon dots from an immunomodulatory plant for cancer cell imaging, free radical scavenging and metal sensing applications. Nanomedicine 16(23), 2039–2059 (2021).
  CASGoogle Scholar
• 54. Abdel-Hafez SM, Hathout RM, Sammour OA. Curcumin-loaded ultradeformable nanovesicles as a potential delivery system for breast cancer therapy. Colloids Surf. B Biointerfaces 167, 63–72 (2018).
  Medline CASGoogle Scholar
• 55. Das B, Sen SO, Maji R, Nayak AK, Sen KK. Transferosomal gel for transdermal delivery of risperidone: formulation optimization and ex vivo permeation. J. Drug Deliv. Sci. Technol. 38, 59–71 (2017).
  CASGoogle Scholar
• 56. Hasibi F, Nasirpour A, Varshosaz J et al. Formulation and characterization of taxifolin-loaded lipid nanovesicles (liposomes, niosomes, and transfersomes) for beverage fortification. Eur. J. Lipid Sci. Technol. 122(2), 201900105 (2020).
  Google Scholar
• 57. Kassem MA, Aboul-Einien MH, El Taweel MM. Dry gel containing optimized felodipine-loaded transferosomes: a promising transdermal delivery system to enhance drug bioavailability. AAPS PharmSciTech 19, 2155–2173 (2018).
  Medline CASGoogle Scholar
• 58. Ahad A, Al-Saleh AA, Al-Mohizea AM et al. Pharmacodynamic study of eprosartan mesylate-loaded transfersomes Carbopol^® gel under Dermaroller^® on rats with methyl prednisolone acetate-induced hypertension. Biomed. Pharmacother. 89, 177–184 (2017).
  Medline CASGoogle Scholar
• 59. Vasanth S, Dubey A, GS R et al. Development and investigation of vitamin C-enriched adapalene-loaded transfersome gel: a collegial approach for the treatment of acne vulgaris. AAPS PharmSciTech 21, 1–17 (2020).
  Google Scholar
• 60. Singh S, Verma D, Mirza MA et al. Development and optimization of ketoconazole loaded nano-transfersomal gel for vaginal delivery using Box-Behnken design: in vitro, ex vivo characterization and antimicrobial evaluation. J. Drug Deliv. Sci. Technol. 39, 95–103 (2017).
  CASGoogle Scholar
• 61. Dixit K, Mohapatra D, Senapati P, Sahu A. Formulation development and evaluation of Lawsonia inermis extract loaded hydrogel for wound dressing application. Indian J. Pharm. Sci. 84(4), 848–862 (2022).
  CASGoogle Scholar
• 62. El-Feky GS, Mona M, Mahmoud AA. Flexible nano-sized lipid vesicles for the transdermal delivery of colchicine; in vitro/in vivo investigation. J. Drug Deliv. Sci. Technol. 49, 24–34 (2019).
  CASGoogle Scholar
• 63. Omar MM, Eleraky NE, El Sisi AM, Ali Hasan O. Development and evaluation of in-situ nasal gel formulations of nanosized transferosomal sumatriptan: design, optimization, in vitro and in vivo evaluation. Drug Des. Devel. Ther. 13, 4413–4430 (2019).
  Medline CASGoogle Scholar
• 64. Abd El-Alim SH, Kassem AA, Basha M, Salama A. Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: in vitro and in vivo evaluation. Int. J. Pharm. 563, 293–303 (2019). • Provides detailed experimental information on transferosome and other vesicular formulations.
  MedlineGoogle Scholar
• 65. Sharma N, Singh S. Central composite designed ezetimibe solid dispersion for dissolution enhancement: synthesis and in vitro evaluation. Ther. Deliv. 10(10), 643–658 (2019).
  Medline CASGoogle Scholar